Table 1.
Authors | Date of Publication | Country | Study Design | Patients | Age, Years, Mean (SD) | Sex, n (%) Male | Main Comorbidities/ Lifestyle factors Associated | Race/Ethnicity | Other Associated Psychiatric Diseases in This Study | Medication | Telomere Measurement and Tissue | Measurement of Psychiatric Disorder | Level of Depression | Telomere Lenght | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Garcia-Rizo et al. [16] | Feburary 2013 | Spain | Case-control study | Control | 70 (For telomere content, n = 48) | 27.8 (6.8) | (62.2%) | BMI: 23.7 (2.9), Mean number of cigarettes/day: 6.2 (8.3) | NA | - | NA | mTL, Southern blot, Leukocytes | SCID | MDD (n = 15) | Shortened telomere are present early in the course of depression independently of the confounding. Abnormal glucose tolerance and lymphopenia were also related to MDD |
Case | 15 (For telomere content, n = 9) | 30.7 (10.0) | 60% | BMI: 23.4 (4.1), Mean number of cigarettes/day: 9.9 (12.7) | NA | ||||||||||
Chen et al. [17] | December 2014 | USA | Case-control study | Control | 20 | Patients were individually matched on age (±3 years), gender and ethnicity Full patients data were not available | - | NA | mTL, PCR, Leukocytes | QIDS, SCID | MDD (n = 20) | In healthy controls, greater ACE exposure was associated with shorter LTL but was unassociated with telomerase activity. In MDD, greater ACE exposure was unrelated to LTL but was associated with increased telomerase activity and with a higher telomerase: | |||
Case | 20 | ||||||||||||||
Tyrka et al. [18] | January 2016 | USA | Case-control study | Control | 113 | 28.5 (9.2) | 50 (44.2%) | Smokers (8.3%) | White (82.3%) | Adversities, depression, PTSD and anxiety | NA | mTL, qPCR, Leukocytes | SCID, STAI, PSS, CD-RISC | Significantly higher mtDNA copy numbers and shorter telomeres were seen in individuals with major depression, depressive disorders, and anxiety disorders, as well as those with parental loss and childhood maltreatment. | |
Case 1—Adverity with no psychiatric disorder | 66 | 31.3 (11.1) | 26 (39.4%) | Smokers (7.8%) | White (80.3%) | ||||||||||
Case 2—Psichyatric disorder with no adversity | 39 | 30.7 (10.4) | 15 (38.5%) | Smokers (7.7%) | White (92.3%) | MDD (n = 6), depressive (n = 7) | |||||||||
Case 3—Adversity and psychiatric disorder | 72 | 34.8 (12.0) | 22 (30.6%) | Smokers (17.1%) | White (81.9%) | MDD (n = 7), depressive (n = 18) | |||||||||
Prabu et al. [19] | July 2020 | India | Case-control study | Control—NGT and no depression | 40 | 48 (10) | 21 (52.5%) | BMI: 26 (4.2) | NA | - | 66 T2DM patients were on anti-diabetic medication alone. 14 T2DM patients were on anti-diabetic plus antihypertensive/statin medication. |
RTL, rQ-PCR, blood sample | PHQ-9, PHQ-12 | NA | Patients with type 2 diabetes and depression exhibited increased circulatory levels of miR-128 and serum cortisol and shortened telomeres. |
Case 1—NGT with depression | 40 | 50 (11) | 20 (50%) | BMI: 26.8 (5.8) | |||||||||||
Case 2—T2DM and no depression | 40 | 54 (6) | 21 (52.5%) | BMI: 25.4 (4.9) | |||||||||||
Case 3—T2DM with depression | 40 | 54 (7) | 21 (52.5%) | BMI: 25.5 (3.7) | |||||||||||
Vincent et al. [20] | February 2017 | United Kingdom | Case-control study | Control | 100 | 50.84 (16.89) | F:51 (51%) M:49 (49%) | BMI: 26.89 (5.39) | White | - | NA | RTL, qPCR, Leukocytes | CIS-R, SCAN | - | Shortened RTL was specifically associated with childhood physical neglect, but not the other subtypes of maltreatment or depression case/control status. |
Case | 80 | 48.63 (13.9) | F: 52 (65%) M: 28 (35%) | BMI: 28.47 (6.87) | Mild depression (n = 15), moderate or severe depression (55), mixed depression/anxiety (n = 10) | ||||||||||
Hoen et al. [21] | August 2012 | Netherlands | Case-control study | Control | 980 | 53.7 (11.3) | F: 551 M: 465 | Smoking (n = 225; 77%), Alcohol consumption (n = 788; 80%), Sedentarism (n = 505; 52%) | NA | Anxiety | mTL, PCR, Leukocytes | CIDI | NA | No association was found between depressive disorders and shorter telomeres at follow-up. Anxiety disorders predicted shorter telomere length at follow-up in a general population cohort. |
|
Case | 97 | 51.3 (10.7) | F: 62 M: 36 |
Smokers (n = 32; 65%); Alcohol consumption (n = 78; 80%), Sedentarism (n = 50; 52%) | Antidepressant use (n = 14; 15%) | ||||||||||
Bersani et al. [22] | October 2015 | USA | Cross-sectional study | Control | 76 | 34.64 (9.17) | All male | Years of education (mean ± SD): 14.79 ± 2.44, current smokers (n): 11 | Hispanic (n = 35); Non Hispanic (n = 42)* | PTSD | Statins (n = 2), NSAIDs (n = 5), antidepressants (n = 13), antibiotics (n = 1), hormone drugs for prostate cancer (n = 1), analgesics (n = 1) | RTL, PCR, Granulocytes | CAPS, BDI-II, ETI, SCL-90-GSI, PSS, PANAS | PTSD associated with MDD (n = 17) | Early trauma, severity of perceived stress and general psychopathological symptoms are more closely associated with shorter TL than is the severity of core diagnostic symptoms of PTSD or MDD |
Hoen et al. [23] | September 2011 | USA | Cohort study | Control | 746 | 68.1 (10.6) | 634 (85%) | Smoking (n = 131, 18%) | White (85%) | - | CDIS-IV, PHQ-9 | Depression is associated with reduced leukocyte telomere length in patients with coronary heart disease but does not predict 5-year change in telomere length | |||
Case | 206 | 61.7 (10.8) | 142 (69%) | Smoking (n = 58, 28%) | White (60%) | Antidepressant use (n = 99, 48%) | mTL, qPCR, Leukocytes | Major Depression | |||||||
AlAhwal et al. [24] | February 2019 | Saudi Arabia | Cross-sectional study | Cohort—Patients with colorectal cancer in Saudi Arabia | 50 | 54.5 (11.8) | 26 (52%) | - | NA | - | - | TL measurement not specified, rQ-PCR and tissue not specified | SCID-I, HDRS | MDD (10%), disthymia (10%), minor depression (4.0%) | TL progressively shortened from no depressive disorder to minor depression to dysthymia to major depressive disorder. TL was also strongly and inversely correlated with severity of depressive symptoms on the HDRS. |
Needham et al. [11] | April 2015 | USA | Cross-sectional study | No depression | 966 | 29.2 (5.9) | 425 (44%) | NA | Non-Hispanic white (50.2%); African american (19.5%); Mexican American (30.3%) | Anxiety | Antidepressant use (n = 32, 3.3%) | RTL, qPCR, Leukocytes | CIDI | Neither depressive nor anxiety disorders were directly associated with telomere length, in young adults. There was suggestive evidence that pharmacologically-treated MD is associated with shorter telomere length, likely reflecting the more severe nature of MD that has come to clinical attention. |
|
MD or depressed affect | 198 | 30.3 (5.8) | 84 (42.4%) | Non-Hispanic white (51.0%); African american (19.7%); Mexican American (29.3%) | Antidepressant use (n = 20, 10.1%) | Depressed affect only (n = 123, 62.1%); Major depression (n = 75, 37.9%) | |||||||||
Verhoeven et al. [25] | April 2018 | USA, Canada and The Netherlands | Cohort study | Year 15 | 977 | 40.5 (3.6) | 338 (34.6%) | Obese: 32.7%, former smoker: 18.7%, current smoker: 19%; heavy drinker: 9.3%; number of somatic diseases, mean (SD): 0.9 (1.1); physical activity, mean (SD): 336 (274) | White (59.4%) | - | Current antidepressant use (n = 67, 6.9%) | mTL, qPCR, Leukocytes | CES-D | CES-D score: 8.5 (7.3); Depression past year (n = 86, 8.8%); Depression life-time (n = 151, 15.5%) | Evidence for a long-term, between-person relationship of depressive symptoms with LTL, rather than a dynamic and direct within-person relationship |
Year 20 | 45.4 (3.6) | Obese: 38.5%, former smoker: 21.5%, current smoker: 15.5%; heavy drinker: 10.3%; number of somatic diseases, mean (SD): 1.0 (1.2); physical activity, mean (SD): 334 (273) | Current antidepressant use (n = 101, 10.3%) | CES-D score: 9.0 (7.8); Depression past year (n = 111, 11.4%); Depression life-time (n = 182, 18.6%) | |||||||||||
Year 25 | 50.4 (3.6) | Obese: 38.5%, former smoker: 21.5%, current smoker: 15.5%; heavy drinker: 10.3%; number of somatic diseases, mean (SD): 1.0 (1.2); physical activity, mean (SD): 335 (272) | Current antidepressant use (n = 109, 11.1%) | CES-D score: 9.0 (7.4); Depression past year (n = 131, 13,4%); Depression life-time (n = 210, 21.5%) | |||||||||||
Verhoeven et al. [26] | June 2016 | Usa and The Netherlands | Cohort study | Baseline | 2936 | 41.8 (13.1) | 33.6% | Obese: 16.7%, former smoker: 33.2, current smoker: 38.7%; heavy drinker: 12.7% | NA | Current anxiety disorder (n = 535, 32.0%) | Tricyclic antidepressants (n = 79, 2.7%); Selective serotonin reuptake inhibitor (n = 502, 17.1), Other antidepressants (n = 164, 5.6%) | RTL, qPCR, Leukocytes | CIDI | Current Depressive diagnosis disorder (n = 389, 23.3%), Control (n = 644, 21.9%), Remitted (n = 620, 21.1%) | Robust associations of depressive and anxiety disorders with shorter telomeres, but interestingly, it did not demonstrate that depressive and anxiety disorders and LTL change together over time, suggesting the absence of a direct within-person relationship. Short LTL is suggested to be either a long-term consequence or an underlying vulnerability factor for depressive or anxiety disorders |
Year 6 | 1883 | 48.6 (12.9) | 34.6% | Obese: 19.8%, former smoker: 42.3%, current smoker: 28.2%; heavy drinker: 9.9% | Current anxiety disorder (n = 190, 36.0%) | Tricyclic antidepressants (n = 56, 3.0%); Selective serotonin reuptake inhibitor (n = 224, 11.9), Other antidepressants (n = 104, 5.5%) | Current Depressive diagnosis disorder (n = 159, 30.1%), Control (n = 440, 23.4%), Remitted (n = 915, 48.6%) | ||||||||
Whisman et al. [27] | February 2017 | USA | Cross-sectional study | 3609 | 67.0 (10.0) | 1404 (43.7) | BMI, mean (SD): 28.4 (6.0), Diabetes (19,5%), Cancer (14.1%), Heart disease (25.0), Stroke (6.0) | White (87.7%), Black (9.7%), Latin (7.4%), Other (2.6%) | - | NA | NA, RT-qPCR, saliva sample | CES-D | Depressive symptoms, mean (SD): 1.5 (2.0) | Higher levels of depressive symptoms were associated with shorter salivary telomeres in men, and this association was incremental to several potential confounds. | |
Lin et al. [28] | February 2015 | USA | Cross-sectional study | 464 | 64.87 (10.99) | 368 (79.31) | Current smoker (n = 132, 28.45%), former smoker (n = 199, 42.89%), Non-Muscle-Invasive Bladder Cancer (n = 234, 53.67%) |
White (93.1%), Hispanic (3.23%), Black (3.23%), Other (0.44%) | - | NA | RTL, rQ-PCR, Lymphocytes | CES-D, SCID | Alive with CESD < 16 (n = 280, 84.08%), Alive with CES-D ≥16 (63, 67.74%), Dead with CES-D < 16 (n = 53, 15.92%), Dead with CES-D ≥ 16 (n = 30, 32.26%) | Short telomere length and depressive symptoms are associated with bladder cancer mortality individually and jointly. |
|
Zhao et al. [29] | November 2016 | USA | Cross-sectional study | 2175 | 40.4 (17.0) | 847 (38.9%) | BMI: 31.3 (7.5), smoker (36.4%), drinker (58.0%, physical activity, steps/d, mean (SD): 5845.3 (3899.9) | American indians | - | Antidepressant use: 5.2% | RTL, qPCR, Leukocytes | CES-D | None (50.2%), mild (21.9%), moderate (15.6%), severe (12.3%) | Results showed that individuals with a higher level of depressive symptoms had shorter LTL. |
|
Shaffer et al. [30] | October 2012 | USA | Cross-sectional study | 2225 | 48.2 (18.9) | 1115 (50.1%) | BMI: 27.0 (5.5), Diabetes mellitus (n = 101, 4.5%), Previous ischemic heart disease (n = 160, 7.2%) | NA | - | NA | mTL, RT-PCR, Leukocytes | CES-D | Probable depressive disorder (CES-D ≥ 16): (n = 269, 12.1%), Elevated depressive symptoms (CES-D ≥ 10): n = 613 (27.6%) | Concurrent depressive symptoms were not associated with leukocyte telomere length in a large, representative, population-based study. |
|
Chae et al. [31] | January 2016 | USA | Cross-sectional study | 92 | 43.86 (5.73) | 92 (100%) | Smorkers (n = 51, 55.4%) | African american | Anxiety, mean (SD): 5.02 (3.86) | Medication use (non-specified): (n = 29, 31.5%) | mTL, qPCR, Leukocytes | CES-D, HADS | Depression, mean (SD): 7.51 (4.86) | Racial discrimination was associated with shorter LTL among those with lower levels of depressive symptoms |
|
Phillips et al. [32] | April 2013 | United Kingdom | Cross-sectional study | Youngest cohort | 337 | 36.6 (0.67) | 47% | Smoker (n = 76, 23%) | NA | - | Antidepressant use (n = 18, 5%) | mTL, qPCR, Leukocytes | HADS | Depression score at wave 5: 3.2 (4.54) | Depressive symptoms are longitudinally associated with shorter telomere length, but only in younger adults. |
Middle cohort | 441 | 57.1 (111) | 45% | Smoker (n = 111, 25%) | Antidepressant use (n = 52, 12%) | Depression score at wave 5: 4.1 (4.66) | |||||||||
Older cohort | 285 | 76.1 (0.84) | 45% | Smoker (n = 38, 13%) | Antidepressant use (n = 33, 12%) | Depression score at wave 5: 4.4 (4.50) | |||||||||
Liu et al. [33] | April 2014 | China | Case-control study | Control 1—NGT and no depression | 46 | 51.22 (8.32) | 19 (41.30) | Current smokers (n = 12, 26.09%); Current drinkers (n = 7, 15.22%) |
NA | - | NA | RTL, qPCR, Leukocytes | HADS-D | NA | Oxidative stress contributes to both telomere length shortening and depression development in newly diagnosed type 2 diabetic patients, while in depression status, some other mechanisms besides oxidative stress may also affect the telomere length |
Control 2—NGT with depression | 6 | 55.33 (6.56) | 3 (50.00) | Current smokers (n = 2, 33.33%); Current drinkers (n = 1, 16.67%) |
|||||||||||
Case 1—T2DM and no depression | 54 | 54.83 (8.58) | 24 (44.44) | Current smokers (n = 16, 29.63%); Current drinkers (n = 11, 20.37%) |
|||||||||||
Case 2—T2DM with depression | 17 | 54.71 (8.10) | 10 (58.82) | Current smokers (n = 5, 29.41%); Current drinkers (n = 2, 11.76%) |
|||||||||||
Wang et al. [34] | April 2017 | Sweden | Case-control study | Control | 320 | 44.6 (12.5) | 197 (62) | Smokers—NA | NA | - | Telomere length, as compared with healthy controls, is shortened in patients with depression, anxiety and stress and adjustment disorders |
||||
Case | 181 | 41.9 (11.1) | 22 (12) | Smokers (n = 27, 15%) | Antidepressant use (n = 63, 35%) | mTL, rQ-PCR, Leukocyte | PHQ-9, HADS-A/HADS-D, MADRS-S | Baselines—Median score (IQR): MADRS-S—20 (14–25); HAD-D—8 (6–11); HAD-A—12 (9–15); PHQ-9—13 (9–17) | |||||||
Schaakxs et al. [35] | June 2014 | The Netherlands | Case-control study | Control | 128 | 70.1 (7.2) | 49 (38.3) | Cigarette years, median (IQR)—170.00 (598.75); moderate drinker, n (%)—99 (77.3); heavy drinker, n (%)—12 (9.4);years of education, mean (SD): 12.5 (3.5); Obesity, n (%): 26 (20.3%); physical activity, median (IQR): 2.61 (2.96) | NA | - | - | mTL, qPCR, Leukocyte | CIDI, IDS, BAI, AS | - | Mean TL did not differ between depressed persons and never-depressed comparisons |
Case | 355 | 70.6 (7.4) | 120 (33,8) | Cigarette years, median (IQR)—100.00 (435.00); moderate drinker, n (%)—200 (56.3); heavy drinker, n (%)—15 (4.2); years of education, mean (SD): 10.3 (3.4); Obesity, n (%): 60 (16.9%); physical activity, median (IQR): 1.60 (2.96) | TCA, n (%): 78 (22.0); SSRI, n (%): 94 (26.6); Other antidepressants, n (%): 101 (28.5); Benzodiazepine use, n (%): 141 (39.7) |
MDD, n (%): 249 (70.1); dysthymia, n (%): 6 (1.7); Co-morbid MDD and dysthymia, n (%): 92 (25.9%) | |||||||||
Wolkowitz et al. [36] | May 2011 | USA | Case-control study | Control | 17 | 36.6 (11.8) | 6 (35%) | BMI: 24.8 (3.7); Daily current tobacco use (6%), Years of education, mean (SD): 15.82 (2.28), Yale Physical Activity Survey, mean (SD): 3.11(0.90) | Caucasian (71%), African-American (18%), Asian (6%) Other or Mixed (5%) |
NA | mTL, PCR, Leukocyte | HDRS, SCID, ATHF | The depressed group, as a whole, did not differ from the controls in telomere length. However, telomere length was significantly inversely correlated with lifetime depression exposure, even after controlling for age |
||
Case | 18 | 36.8 (11.0) | 6 (33%) | BMI: 26.3 (5.9); Daily current tobacco use (0%), Years of education, mean (SD): 15.28 (2.06), Yale Physical Activity Survey, mean (SD): 2.10(1.26) | Caucasian (72%), African-American (17%), Asian (6%) Other or Mixed (5%) |
- | NA | ||||||||
Georgin-Lavialle et al. [37] | January 2014 | France | Cross-sectional study | 19 | 43.42 (16.97) | 4 (21%) | NA | Caucasian (100%) | - | - | mTL, rQ-PCR, Leukocytes | DSM-IV, BDI-II, PSS | - | Telomere length was correlated to perceived stress (r = 0.77; p = 0.0001) but not to depression in our population. |
|
Verhoeven et al. [38] | November 2013 | USA and The Netherlands | Cohort study | Control | 510 | 40.5 (14.9) | 203 (39.8%) | Obesity (13.5%), former smoker (35.6%), current smoker (26.1%), heavy drinker (11.8%), Physical activity (in 1000 MET-minutes per week) (mean ± S.D.): 3.8 (3.0) | NA | - | SSRI (0.4%), benzodiazepine use (0.4%) | mTL, qPCR, Leukocyte | CIDI | IDS score, mean (SD): 5.4 (3.6) | Within the current MDD patients, separate analyses showed that both higher depression severity and longer symptom duration in the past 4 years were associated with shorter TL. The study also confirmed the imprint of past exposure to depression, as those with remitted MDD had shorter TL than controls. |
Case 1: Remitted MDD | 802 | 43.5 (12.5) | 238 (29.7%) | Obesity (16.0%), former smoker (26.9%), current smoker (39.8%), heavy drinker (12.3%), Physical activity (in 1000 MET-minutes per week) (mean ± S.D.): 3.8 (3.0) | Comorbid anxiety disorder: 36.9% | TCA (2.9%), SSRI (16.4%), other antidepressant (3.7%), benzodiazepine use (4.4%) | IDS score, mean (SD): 18.0 (10.2) | ||||||||
Case 2: Current MDD | 1095 | 40.7 (12.1) | 357 (32.6%) | Obesity (20.4%), former smoker (27.8%), current smoker (45.6%), heavy drinker (13.5%), Physical activity (in 1000 MET-minutes per week) (mean ± S.D.): 3.3 (3.1) | Comorbid anxiety disorder: 65.7% | TCA (4.1%), SSRI (29.6%), other antidepressant (11.0%), benzodiazepine use (14.6%) | IDS score, mean (SD): 32.6 (12.2) | ||||||||
Putermanet et al. [39] | October 2013 | Cohort study | Control | 743 | 68.2 (10.5) | 84.7% | BMI: 28.29 (5.31), current smoking (17.6%), not at all physical activity (17.4%) | White (60.3%) | Statins (66.8%), Aspirin (72.9%), ARBs and ACEi (52.5%), Antidepressants (10.6%) | RTL, qPCR, Leukocytes | CDIS-IV | MDD was significantly related to LTL at 1 SD below the mean of multisystem resiliency, but not at 1 SD above the mean. This study suggests that MDD associations with biological outcomes should be examined within a psychosocial–behavioral context, because this context shapes the nature of thedirect relationship. |
|||
Case | 205 | 61.7 (10.8) | 143(69.8%) | BMI: 29.01 (5.68), current smoking (28.4%), not at all physical activity (22.9%) | White (60.0%) | Statins (58.6%), Aspirin (73.9%), ARBs and ACEi (50.2%), Antidepressants (48.8%) | NA | ||||||||
Blom et al. [40] | November 2015 | Case-control study | Control | 63 | 15.8 (0.2) | 22 (35.18%) | NA | NA | NA | STL, qPCR, saliva sample | Adolescents with major depressive disorder exhibited significantly shorter telomere length and significantly smaller right, but not left hippocampal volume. | ||||
Case | 54 | 15.9 (0.2) | 29 (53.97%) | Generalized anxiety disorder: 16 Social anxiety disorder: 2 Panic disorder: 1 Specific phobia: 4 Posttraumatic stress disorder: 5 Adjustment disorder: 1 Attention deficit hyperactivity disorder: 8 Alcohol/substance dependence: 1 Conduct disorder: 2 Oppositional defiance disorder: 3 Eating disorder (not otherwise specified): 2 |
CTQ, BDI-II, CDRS | Beck Depression Inventory II: 26.7 (1.5); Children’s Depression Inventory: 24.1(1.1) | |||||||||
Vance et al. [41] | April 2018 | USA | Cohort study | Control | 67 | 44.1 (14.0) | 28 (42%) | Highest educational level: Graduate school (33%), College graduate (42%), Partial college (19%), High school graduate or lower (6%). Living with partner/married: 46%. BMI: 24.3 (3.8). Past year exercise level, more than once a week: (91%). Lifetime alcohol or substance use disorder: (10%). Cigarette smoking pack-years, mean (SD): 8.0 (17.3) | White: 73%; Hispanic/Latino: 3% | RTL, qPCR, Leukocyte | MADRS, HAM-A, PSS, ETISR-SF, TEQ | Individuals with MDD at baseline had greater LTL shortening over two years than individuals without MDD (p = 0.03), even after controlling for differences in age, sex, and body mass index (BMI). In the sub-sample of individuals with MDD diagnoses at baseline, no significant associations between LTL change and symptom severity or duration were found. |
|||
Case | 50 | 42.7 (13.2) | 24 (48%) | Highest educational level: Graduate school (18%), College graduate (40%), Partial college (28%), High school graduate or lower (18%). Living with partner/married: 18%. BMI: 26.0 (4.7). Past year exercise level, more than once a week: (63%). Lifetime alcohol or substance use disorder: (22%). Cigarette smoking pack-years, mean (SD): 6.8 (12.5) | White: 82%; Hispanic/Latino: 4% | Antidepressant use >6 months: 52% | MDD, n (%): 15(37%) | ||||||||
Starnino et al. [42] | October 2016 | Canada | Cohort study | 132 | 45.34 (11.16) | 54 (40,9%) | Glasses of alcohol/week, mean (SD): 3.84 (5.38); Smoker n (%): 19(14%), BMI: 25.35 (5.00) | NA | Anxiety and hostility | - | RTL, qPCR, Leukocyte | BDI-II, BAI | Beck Depression Inventory-II, mean (SD): 7.64 (8.21) | Shorter TL was observed among individuals high in defensiveness and depressive symptoms, as well as in those with less hostility and anxiety. Telomere length is associated with psychological burden though the direction of effect differs depending on the psychological variables under study | |
Wang et al. [43] | September 2019 | China | Cross-sectional study | 1742 | 63.6 (4.9) | 819 (47.0%) | Education level, n (%): Illiterate: 1020 (58.6), Primary: 432 (24.8), Junior: 196 (11.3), Senior or above: 94 (5.4) |
NA | - | NA | RTL, q-PCR, Leukocyte | GDS | Mild depressive, n (%): 155 (8.9) Severe depressive, n (%) 39 (2.2) |
Depressive symptoms was negatively correlated with TL in the overall sample. Depressive symptoms significantly mediated the relationship between religiosity and TL (explaining 31.8% of the total variance) in the 65 years and older subgroup | |
Wikgren et al. [44] | September 2011 | Sweden | Case-control study | Control | 451 | 58.9 (11.6) | 224 (50%) | BMI: 26.1 (3.5), smoking, n (%): 50 (11%) | NA | - | - | NA, qPCR, Leukocytes | BDI, BAI, CES-D, PSQ | CES-D, Median Score (IQR): 6 (3–10) | TL was shorter among patients compared with control subjects (277 base pairs, p = 0.001). Overall, short TL was associated with a hypocortisolemic state (low post-DST cortisol and high percentage of cortisol reduction after the DST) among both patients and control subjects but more pronounced among patients. |
Case | 91 | 60.4 (13.1) | 36 (40%) | BMI: 26.6 (3.7), smoking, n (%): 14 (15%) | Antidepressant use, n (%): 81 (89%) | CES-D, Median Score (IQR): 11 (6–22) | |||||||||
Szebeni et al. [45] | June 2014 | USA | Case-control study | Control | 14 | 51 (5) | 13 (93%) | NA | NA | - | NA | RTL, PCR, white matter oligodendrocytes | NA | Relative telomere lengths in white matter oligodendrocytes, but not astrocytes, from both brain regions were significantly shorter for MDD donors as compared to matched control donors |
|
Case | 14 | 51 (5) | 14 (93%) | NA | NA | - | NA | MDD (100%) | |||||||
Liu et al. [46] | July 2017 | Sweden | Cross-sectional study | 894 | Age, years, median (IQR): 46 (39, 54) | 304 (34%) | Education (%): 0–12 years (51.8%), More than 12 years (48.2%), Obesity (7.4%), Smokers (22.7%), Physical exercise regularity (54.2%) | NA | - | NA | RTL, qPCR, saliva | DSM-IV, AVSI, AVAT | - | In females, depressive status and age had direct negative effects on TL. For males, the effects of stressors and depressive status on TL were mediated by social interaction and the coping strategy worry. In females, no mediation effect of social interaction and coping strategy was detected. | |
Boeck et al. [47] | June 2018 | Germany | Case-control study | Control | 21 | 57.5 (5.7) | 0% | BMI: 24.5 (3.0); Smoking, yes, n (%): 3(14.3%); Physical activity, yes, n (%):18 (85.7%) | NA | - | Medication, n (%): Antihypertensive drugs: 3 (14.3%), Tyroid hormone: 3 (14.3%), Sedatives: 1 (4.8%) |
mTL, qFISH, PBMC | BDI-II | BDI-II sum score (mean ± S.D.): 2.1 ± 2.2 | All of the observed TL changes were signifcantly or marginally signifcantly associated with depressive symptom severity as assessed by the Becks Depression Inventory (BDI-II) sum score. Furthermore, the BDI-II also showed a signifcant negative correlation with TL in memory T helper cells |
Case | 18 | 59.3 (6.6) | 0% | BMI: 29.2 (7.5); Smoking, yes, n (%): 8(44.4%); Physical activity, yes, n (%):11 (61.1%) | Medication, n (%): Antidepressants: 13 (72.2%) Antipsychotics: 5 (27.8%) Antihypertensive drugs: 7 (38.9%) Tyroid hormone: 5 (27.8%) Sedatives: 5 (27.8%) Analgesics: 3 (16.7%) Laxatives: 2 (11.1%) Vitamins (B1,B6,B12): 1 (5.6%) Statins: 1 (5.6%) |
BDI-II sum score (mean ± S.D.): 23.8 ± 10.9 | |||||||||
Jiménez et al. [48] | October 2018 | Colombia | Case-control study | Control | 52 | 21 (3) | F:36 (69%) M:16 (31%) | NA | latin | - | NA | RTL, MMqPCR, Leukocyte | PHQ-9, CES-D, HADS, CTQ | - | Correlation in the clinically significant depressive symptoms group between TL and sexual abuse |
Case | 40 | 21 (3) | F:34 (85%) M:6 (15%) | ||||||||||||
Wium-Andersen et al. [49] | January 2017 | Denmark | Cross-sectional study | Quartile 1 | 16,820 | 52 (42–61) | 6943 (41%) | Never smokers, No. (%): 7029 (42), Drinks/week, median (IQR):7 (3–14), Less than 3 years of education, No. (%): 10,062 (60), Low leisure time physical activity, inactive or less than 2–4 h light/day, No. (%): 8658 (51%), BMI, median (IQR): 25 (23–28), chronic disease, No. (%): 5647 (34%) |
- | Prescription antidepressant medication, No (%): 7748 (12%) | mTL, modified MMqPCR, Leukocyte | ICD-8, ICD-10 | NA | Attendance at hospital for depression was associated with short telomere length cross-sectionally, but not prospectively. Further, purchase of antidepressant medication was not associated with short telomere length cross-sectionally or prospectively. The genetic analyses suggested that telomere length was not causally associated with attendance at hospital for depression or with purchase of antidepressant medication. |
|
Quartile 2 | 16,829 | 55 (45–65) | 7391 (44%) | Never smokers, No. (%): 6557 (39), Drinks/week, median (IQR):7 8 (3–15), Less than 3 years of education, No. (%): 10,260 (61), Low leisure time physical activity, inactive or less than 2–4 h light/day, No. (%): 8931 (53), BMI, median (IQR): 25 (23–28), chronic disease, No (%): 6415 (38) |
|||||||||||
Quartile 3 | 16,828 | 59 (49–68) | 7630 (45%) | Never smokers, No. (%): 6096 (36), Drinks/week, median (IQR):8 (4–15), Less than 3 years of education, No. (%): 10,698 (64), Low leisure time physical activity, inactive or less than 2–4 h light/day, No. (%): 9100 (54), BMI, median (IQR): 26 (23–29), chronic disease, No. (%): 7320 (44) |
|||||||||||
Quartile 4 | 16,829 | 64 (54–72) | 8100 (48%) | Never smokers, No. (%): 7029 (42), Drinks/week, median (IQR):7 (3–14), Less than 3 years of education, No. (%): 10,062 (60), Low leisure time physical activity, inactive or less than 2–4 h light/day, No. (%): 8658 (51%), BMI, median (IQR): 25 (23–28), chronic disease, No (%): 5647 (34%) |
NA | ||||||||||
Huzen et al. [50] | January 2010 | The Netherlands and United Kingdom | Cross-sectional study | 890 | 73 (64–79) | 535 (61%) | BMI: 26 (24–30) | NA | - | - | mTL, RT-qPCR, Leukocyte | CES-D, DS14, RAND-36 | Severe depression, n (%): 154 (18%), depressive symptoms only, n (%): 145 (16,3%) | A lower perceived mental health on the RAND-36 score was associated with shorter telomere length. Telomere length was not associated with the CES-D or DS14 score. |
|
Simon et al. [51] | August 2015 | USA | Case-control study | Control | 166 | 41.3 (13.7) | 77 (46%) | Educational level: Graduate school: 35%, College graduate (40%), Partial college (18%), High school graduate or less (7%). Lifetime alcohol or drug abuse/dependence, N (%): 13 (8). BMI: 25.4 (4.2) | White: 68%, Black or African American:17%, Asian:7%, Native American/Alaska Native: 0%, Other: 8%. Not Hispanic/Latino: 90%, Hispanic/Latino: 10% | RTL, RT-qPCR, Southern blot, Leukocytes | DSM-IV, SCID, MADRS, CIRS, TEQ, ETISR-SF, ICG | MADRS Total Score, Mean (SD): 1.9 (2.4) | Our well-characterized, well-powered examination of concurrently assessed telomere length and telomerase activity in individuals with clinically significant, chronic MDD and matched controls failed to provide strong evidence of an association of MDD with shorter LTL, while telomerase activity was lower in men with MDD. |
||
Case | 166 | 41.3 (13.8) | 77(46%) | Educational level: Graduate school: 20%, College graduate (35%), Partial college (25%), High school graduate or less (17%). Lifetime alcohol or drug abuse/dependence, N (%): 47 (28%) | White: 78%, Black or African American:11%, Asian:4%, Native American/Alaska Native: 1%, Other: 4%. Not Hispanic/Latino: 92%, Hispanic/Latino: 7% | Current anxiety disorder (50%), litime anxiety disorder (55%) | Anti-depressant use > 6 months, N (%): 65 (39), Mood stabilizer use > 6 months, N (%): 6 (4), Benzodiazepine use > 6 months, N (%): 19 (11) Antipsychotic use > 6 months, N (%): 10 (6) |
MADRS Total Score, Mean (SD): 28.2 (6.0) | |||||||
Harttman et al. [52] | November 2010 | Germany | Case-control study | Control | 20 | 49.1 (15.2) | 11 (55%) | Smokers (n = 7, 35%) | NA | - | Major depressive disorder is associated with shortened telomeres. However, differences in the applied therapy, the duration of illness, or the severity of depression do not seem to have any influence on telomere length. | ||||
Case | 54 | 49.1 (14.1) | 21 (39%) | Smokers (n = 16, 29.6%) | NA | - | TAD ≤ 1: n = 20, TAD > 1 n = 16 | mTL, Southern blot, Leukocyte | HAM-D | HAM-D, (SD) [Range]: 29.9 (6.0) [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36] | |||||
Karabatsiakis et al. [53] | July 2014 | Germany | Case-control study | Control | 50 | 51.1 (8) | 0% | Years of education, mean (SD): 15.1 (2.4) | NA | - | mTL, qFISH, Leukocyte | BDI | NA | : A history of depression is associated with shortened telomeres in the main effector populations of the adaptive immune system. Shorter telomeres seem to persist in individuals with lifetime depression independently of the severity of depressive symptoms. |
|
Case 1—Lifetime depressed with irrelevant symptoms | 24 | 53.1 (7.2) | 0% | Years of education, mean (SD): 14.1 (2.1) | SSRI/ SNRI intake, n (%): 10 (41.7%) | ||||||||||
Case 2—Relevant symptoms of depression | 20 | 53.8 (7.6) | 0% | Years of education, mean (SD): 14.2 (2.9) | SSRI/ SNRI intake, n (%): 9 (45%) | ||||||||||
Solomon et al. [54] | July 2017 | Israel | Cohort study | 99 | 63.6 (3.7) | NA | Years of education (M, SD): 14, 3.7, Physical exercising regularly: 62 (62.6%) Smoking on a regular basis: 21 (21.2%) |
NA | PTSD | NA | mTL, Southern blot, Leukocyte | SCL-90 | NA | Ex-POWs had shorter telomeres compared to controls (Cohen’s d = 0.5 indicating intermediate effect). Ex-POWs with chronic depression had shorter telomeres compared to those with delayed onset of depression (Cohen’s d = 4.89), and resilient ex-POWs (Cohen’s d = 3.87), indicating high effect sizes. |
|
Verhoeven et al. [55] | November 2019 | The Netherlands | Cohort study | 2032 | 42.5 (12.8) | 665 (32.7%) | NA | European ancestry: 2032 (100%) | - | NA | RTL, qPCR, Leukocyte | CIDI, DSM-IV, IDS-SR, NEO-FFI | Lifetime depression diagnosis (% yes, N): 83.1, 1688 Depression severity (average 6-year IDS score) (mean ± S.D.): 19.0 (12.0) |
The use of genetic methods in this paper indicated that the established phenotypic association between telomere length and depression is unlikely due to shared underlying genetic vulnerability. These findings suggest that short telomeres in depressed patients may simply represent a generic marker of disease or may originate from non-genetic environmental factors |
|
Mamdani et al. [56] | September 2015 | USA | Case-control study | Control | 10 | 48 (13.0) | 7 (70%) | NA | NA | Schizofrenia and bipolar disorder | NA | RTL, qPCR, brain tissue | UCCIB psychological autopsy protocol |
A significant decrease in telomere length was observed specifically in the HIPP of MDD subjects even after controlling for age. In the HIPP of MDD subjects, several genes involved in neuroprotection and in stress response showed altered levels of mRNA. | |
Case | 10 | 47.3 (11.5) | 3 (30%) | NA | NA | MDD: 10 (100%) |
List of abbreviations: mTL—mean telomere length; RTL—relative telomere length; PCR—Polymerase Chain Reaction; qPCR—Quantitative PCR; RT-PCR—real-time PCR; rQ-PCR or RT-qPCR—real-time quantitative PCR; MMqPCR—monochrome multiplex quantitative PCR; qFISH—Quantitative Fluorescent in situ hybridization; T2DM—Type 2 diabetes mellitus; NGT—normal glucose tolerant; mtDNA—mitochondrial DNA; TCA—tricyclic antidepressants; SSRI—selective serotonin reuptake inhibitor; ARBs—Angiotensin II receptor blockers; ACEi—Angiotensin Converting Enzyme inhibitors; TAD—Total antidepressant dose; HIPP—hippocampus. POW—prisoners of war; ACE—adverse childhood experiences: DST—dexamethasone suppression test; BMI—Body Mass Index—Mean, (SD).